Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Belinostat: Updated Phase II data

The partners reported updated data from a Phase II trial in patients with peripheral T cell

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE